About the Journal
Advancing Pharmaceutical Research Through Scientific Excellence
The Journal of Integrated Pharmaceutical and Allied Sciences (JIPAAS) is an international, peer-reviewed, open-access journal dedicated to publishing high-quality research that advances pharmaceutical sciences, biomedical innovation, clinical practice, and interdisciplinary healthcare.
The Journal of Integrated Pharmaceutical and Allied Sciences (JIPAAS) is an international, peer-reviewed, open-access scholarly journal committed to advancing excellence in pharmaceutical, biomedical, clinical, and allied health sciences. The journal provides a rigorous and globally accessible platform for the publication of innovative, high-quality research that promotes scientific discovery, interdisciplinary collaboration, and evidence-based healthcare.
JIPAAS welcomes contributions from researchers, clinicians, academicians, healthcare professionals, industry scientists, and policymakers worldwide. By fostering collaboration across scientific disciplines, the journal seeks to bridge the gap between pharmaceutical research, clinical practice, public health, and emerging healthcare technologies. Its broad scope reflects the increasingly interdisciplinary nature of modern biomedical research and its role in improving patient outcomes and global health.
The journal publishes Original Research Articles, Review Articles, Systematic Reviews, Meta-Analyses, Short Communications, Case Reports, Study Protocols, Perspectives, Editorials, and Letters to the Editor spanning diverse areas of pharmaceutical sciences and allied health disciplines. Every manuscript undergoes a rigorous double-blind peer-review process conducted by independent experts to ensure scientific quality, methodological rigor, ethical integrity, and clinical relevance. JIPAAS is committed to upholding internationally recognized standards of publication ethics and editorial best practices, following the principles and recommendations of organizations including COPE, ICMJE, WAME, and DOAJ.
As a fully Open Access journal, JIPAAS is dedicated to making scientific knowledge freely available to the global research community without subscription barriers. Published quarterly with continuous online-first publication, the journal aims to accelerate the dissemination of impactful discoveries while promoting transparency, reproducibility, and responsible scientific communication. Each published article is assigned a persistent Crossref Digital Object Identifier (DOI) to ensure long-term discoverability, citation, and accessibility.
JIPAAS strives to become a trusted international forum for transformative research that advances pharmaceutical innovation, strengthens healthcare practice, informs public health policy, and contributes to improving health outcomes worldwide. Through editorial excellence, scientific integrity, and a commitment to open scholarship, the journal aspires to support the next generation of discoveries that shape the future of medicine and healthcare.
